Ruby Gupta

441 total citations
33 papers, 285 citations indexed

About

Ruby Gupta is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ruby Gupta has authored 33 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Ruby Gupta's work include Renal cell carcinoma treatment (8 papers), Prostate Cancer Treatment and Research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Ruby Gupta is often cited by papers focused on Renal cell carcinoma treatment (8 papers), Prostate Cancer Treatment and Research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Ruby Gupta collaborates with scholars based in United States, India and United Kingdom. Ruby Gupta's co-authors include Ishmael Jaiyesimi, Vishal Jindal, Jorge A. García, Mandeep Singh Rahi, Kulothungan Gunasekaran, Moshe Chaim Ornstein, Brian I. Rini, Kimberly D Allman, Pedro C. Barata and Laura S. Wood and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ruby Gupta

30 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruby Gupta United States 10 126 88 83 55 52 33 285
Mónica Enguita‐Germán Spain 10 162 1.3× 106 1.2× 90 1.1× 29 0.5× 22 0.4× 21 358
Nicola Susca Italy 9 84 0.7× 84 1.0× 113 1.4× 63 1.1× 24 0.5× 20 325
Yasser El-Gohary United States 7 97 0.8× 184 2.1× 161 1.9× 100 1.8× 56 1.1× 12 423
Gemma María Muñoz‐Molina Spain 6 111 0.9× 69 0.8× 79 1.0× 47 0.9× 17 0.3× 52 250
Carlo Putzu Italy 9 151 1.2× 170 1.9× 65 0.8× 37 0.7× 14 0.3× 22 301
Dong Won Baek South Korea 10 37 0.3× 126 1.4× 36 0.4× 29 0.5× 63 1.2× 52 285
Fuat Demirelli Türkiye 11 97 0.8× 135 1.5× 25 0.3× 46 0.8× 11 0.2× 34 296
Naoto Kitahara Japan 11 259 2.1× 173 2.0× 81 1.0× 50 0.9× 18 0.3× 23 325
Alain Mina United States 9 49 0.4× 70 0.8× 69 0.8× 40 0.7× 19 0.4× 31 201
Francesca Colonese Italy 10 85 0.7× 171 1.9× 64 0.8× 31 0.6× 10 0.2× 24 367

Countries citing papers authored by Ruby Gupta

Since Specialization
Citations

This map shows the geographic impact of Ruby Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby Gupta more than expected).

Fields of papers citing papers by Ruby Gupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruby Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby Gupta. The network helps show where Ruby Gupta may publish in the future.

Co-authorship network of co-authors of Ruby Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Ruby Gupta. A scholar is included among the top collaborators of Ruby Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruby Gupta. Ruby Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Ruby, et al.. (2022). Therapeutic landscape of advanced HER2-positive breast cancer in 2022. Medical Oncology. 39(12). 258–258. 18 indexed citations
2.
Gupta, Ruby, et al.. (2021). Paradigm shift in the management of metastatic nonsmall cell lung cancer. International Journal of Clinical Practice. 75(11). e14533–e14533. 1 indexed citations
3.
Rahi, Mandeep Singh, et al.. (2021). Hematologic disorders associated with COVID-19: a review. Annals of Hematology. 100(2). 309–320. 57 indexed citations
4.
Gupta, Ruby, et al.. (2021). Celiac Plexus Block Complications: A Case Report and Review of the Literature. Journal of Palliative Medicine. 24(9). 1409–1412. 5 indexed citations
5.
Pond, Gregory R., Archana M. Agarwal, Moshe Chaim Ornstein, et al.. (2021). Clinical Outcomes of Platinum-ineligible Patients with Advanced Urothelial Carcinoma Treated With First-line PD1/L1 Inhibitors. Clinical Genitourinary Cancer. 19(5). 425–433. 17 indexed citations
6.
Gupta, Ruby, et al.. (2020). Evolving Paradigms in the Management and Outcomes of Sarcomatoid Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors. World Journal of Oncology. 11(5). 183–187. 4 indexed citations
7.
Ged, Yasser, Ruby Gupta, Andrea Knežević, et al.. (2020). Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations. BMC Urology. 20(1). 84–84. 10 indexed citations
8.
9.
Fallah, Jaleh, Ruby Gupta, Hong Li, et al.. (2020). Identifying Prostate Surface Antigen Patterns of Change in Patients with Metastatic Hormone Sensitive Prostate Cancer Treated with Abiraterone and Prednisone. Targeted Oncology. 15(4). 477–483. 5 indexed citations
10.
Jindal, Vishal, et al.. (2020). COVID-19 and Hematologic Malignancies: Single Institution Analysis. Blood. 136(Supplement 1). 27–27. 1 indexed citations
11.
Gupta, Ruby, et al.. (2020). Presentation, Management and Outcomes of COVID-19 Patients with Sickle Cell Disease. Blood. 136(Supplement 1). 29–30. 1 indexed citations
12.
13.
Koshkin, Vadim S., Pedro C. Barata, Ruby Gupta, et al.. (2019). Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancer. Investigational New Drugs. 37(3). 559–566. 13 indexed citations
14.
Gupta, Ruby, Moshe Chaim Ornstein, Hong Li, et al.. (2019). Clinical Activity of Ipilimumab Plus Nivolumab in Patients With Metastatic Non–Clear Cell Renal Cell Carcinoma. Clinical Genitourinary Cancer. 18(6). 429–435. 53 indexed citations
15.
Barata, Pedro C., Cristina Magi‐Galluzzi, Ruby Gupta, et al.. (2019). Association of mTOR Pathway Markers and Clinical Outcomes in Patients with Intermediate-/High-risk Prostate Cancer: Long-Term Analysis. Clinical Genitourinary Cancer. 17(5). 366–372. 2 indexed citations
16.
Chen, Yu‐Wei, Ruby Gupta, Moshe Chaim Ornstein, et al.. (2019). Impact of the USPSTF recommendations on prostate cancer stage migration and de-novo metastatic prostate cancer.. Journal of Clinical Oncology. 37(7_suppl). 166–166. 1 indexed citations
17.
Barata, Pedro C., Matthew M. Cooney, Prateek Mendiratta, et al.. (2018). Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer. Investigational New Drugs. 37(2). 331–337. 20 indexed citations
18.
Gupta, Ruby, et al.. (2012). Periodontal manifestations and management of a patient with AV malformation. SHILAP Revista de lepidopterología. 16(2). 266–266. 3 indexed citations
19.
Gupta, Ruby, et al.. (2011). A sequential approach in treatment of perio-endo lesion. SHILAP Revista de lepidopterología. 15(2). 177–177. 14 indexed citations
20.
Gupta, Ruby, et al.. (2011). Evaluation of resorbable membrane in treatment of human gingival isolated buccal recession. Indian Journal of Dental Research. 22(6). 749–749. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mónica Enguita‐Germán Breakdown of academic impact, for papers by Nicola Susca Breakdown of academic impact, for papers by Yasser El-Gohary Breakdown of academic impact, for papers by Gemma María Muñoz‐Molina Breakdown of academic impact, for papers by Carlo Putzu Breakdown of academic impact, for papers by Dong Won Baek Breakdown of academic impact, for papers by Fuat Demirelli Breakdown of academic impact, for papers by Naoto Kitahara Breakdown of academic impact, for papers by Alain Mina Breakdown of academic impact, for papers by Francesca Colonese
Rankless by CCL
2026